Role of thrombopoietin in mast cell differentiation

Annals of the New York Academy of Sciences

Volumn 1106, Issue , 2007, Pages 152-174

  Migliaccio, Anna Rita ^a,b   Rana, Rosa Alba ^c   Vannucchi, Alessandro M ^d   Manzoli, Francesco A ^e  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Apoptosis; Gata1; Mast cells; Mpl; Thrombopoietin

Indexed keywords

THROMBOPOIETIN; TRANSCRIPTION FACTOR GATA 1; GATA1 PROTEIN, HUMAN; MPL PROTEIN, HUMAN; THROMBOPOIETIN RECEPTOR; UNCLASSIFIED DRUG;

BIOLOGICAL ACTIVITY; BONE MARROW; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL LINEAGE; CONFERENCE PAPER; EXTRAMEDULLARY HEMATOPOIESIS; GENE DELETION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; INTESTINE; MAST CELL; MEGAKARYOCYTE; NONHUMAN; PARASITE; REGULATORY MECHANISM; SKIN; STEM CELL; VASCULARIZATION; ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; CYTOLOGY; FLOW CYTOMETRY; METABOLISM; METHODOLOGY; MOUSE; PHYSIOLOGY; REVIEW; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; FLOW CYTOMETRY; GATA1 TRANSCRIPTION FACTOR; HUMANS; MAST CELLS; MEGAKARYOCYTES; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, BIOLOGICAL; RECEPTORS, THROMBOPOIETIN; THROMBOPOIETIN;

EID: 34548439039     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1392.024     Document Type: Conference Paper

References (73)

1. GURISH, M.F. & K.F. AUSTEN. 2001. The diverse roles of mast cells. J. Exp. Med. 194: F1-F5.
2. GALLI, S.J., S. NAKAE & M. TSAI. 2005. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6: 135-142.
3. KITAMURA, Y., M. YOKOYAMA, H. MATSUDA, et al. 1981. Spleen colony-forming cell as common precursor for tissue mast cells and granulocytes. Nature 291: 159-160.
4. KIRSHENBAUM, A.S., J.P. GOFF, T. SEMERE, et al. 1999. Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood 94: 2333-2342.
5. RODEWALD, H.R., M. DESSING, A.M. DVORAK & S.J. GALLI. 1996. Identification of a committed precursor for the mast cell lineage. Science 271: 818-822.
6. REYNOLDS, D.S., R.L. STEVENS, W.S. LANE, et al. 1990. Different mouse mast cell populations express various combinations of at least six distinct mast cell serine proteases. Proc. Natl. Acad. Sci. USA 87: 3230-3234.
7. CHEN, C.C., M.A. GRIMBALDESTON, M. TSAI, et al. 2005. Identification of mast cell progenitors in adult mice. Proc. Natl. Acad. Sci. USA 102: 11408-11413.
8. KITAMURA Y., A. ITO. 2005. Mast cell-committed progenitors. Proc. Natl. Acad. Sci. USA 32: 11129-11130.
9. JAMUR, M.C., A.C. GRODZKI, E.H. BERENSTEIN, et al. 2005. Identification and characterization of undifferentiated mast cells in mouse bone marrow. Blood 105: 4282-4289.
10. MARTELLI, F., B. GHINASSI, B. PANETTA, et al. 2005. Variegation of the phenotype induced by the GATA-1low mutation in mice of different genetic background. Blood 106: 4102-4113.
11. PENNOCK, J.L. & R.K. GRENCIS. 2004. In vivo exit of c-kit+/CD49d(hi)/beta7 +mucosal mast cell precursors from the bone marrow following infection with the intestinal nematode Trichinella spiralis. Blood 103: 2655-2660.
12. ARIZONO, N., T. KASUGAI, M. YAMADA, et al. 1993. Infection of Nippostrongylus brasiliensis induces development of mucosal-type but not connective tissue-type mast cells in genetically mast cell-deficient Ws/Ws rats. Blood 81: 2572-2578.
13. KOBAYASHI, T., T. NAKANO, T. NAKAHATA, et al. 1986. Formation of mast cell colonies in methylcellulose by mouse peritoneal cells and differentiation of these cloned cells in both the skin and the gastric mucosa of W/Wv mice: evidence that a common precursor can give rise to both "onnective tissue-type" and "mucosal" mast cells. J. Immunol. 136: 1378-1384.
14. DAYTON, E.T., P. PHARR, M. OGAWA, et al. 1988. 3T3 fibroblasts induce cloned interleukin 3-dependent mouse mast cells to resemble connective tissue mast cells in granular constituency. Proc. Natl. Acad. Sci. USA 85: 569-572.
15. NOCKA, K., J. BUCK, E. LEVI & P. BESMER. 1990. Candidate ligand for the c-kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors. Embo. J. 9: 3287-3294.
16. DURAND, B., G. MIGLIACCIO, N.S. YEE, et al. 1994. Long-term generation of human mast cells in serum-free cultures of CD34+ cord blood cells stimulated with stem cell factor and interleukin-3. Blood 84: 3667-3674.
17. ROTTEM, M., S. BARBIERI, J.P. KINET & D.D. METCALFE. 1992. Kinetics of the appearance of Fc epsilon RI-bearing cells in interleukin-3-dependent mouse bone marrow cultures: correlation with histamine content and mast cell maturation. Blood 79: 972-980.
18. v mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J. Exp. Med. 162: 1025-1043.
19. MCNEIL, H.P., D.S. REYNOLDS, V. SCHILLER, et al. 1992. Isolation, characterization, and transcription of the gene encoding mouse mast cell protease 7. Proc. Natl. Acad. Sci. USA 89: 11174-11178.
20. YEE, N.S., I. PAEK & P. BESMER. 1994. Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: basis for radiosensitivity of white spotting and steel mutant mice. J. Exp. Med. 179: 1777-1787.
21. TSAI, M., T. TAKEISHI, H. THOMPSON, et al. 1991. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc. Natl. Acad. Sci. USA 88: 6382-6386.
22. MOLLER, C., J. ALFREDSSON, M. ENGSTROM, et al. 2005. Stem cell factor promotes mast cell survival via inactivation of FOXO3a-mediated transcriptional induction and MEK-regulated phosphorylation of the proapoptotic protein Bim. Blood 106: 1330-1336.
23. SUZUKI, K., H. NAKAJIMA, N. WATANABE, et al. 2000. Role of common cytokine receptor gamma chain (gamma(c))- and Jak3-dependent signaling in the proliferation and survival of murine mast cells. Blood 96: 2172-2180.
24. BESMER, P. 1991. The kit ligand encoded at the murine Steel locus: a pleiotropic growth and differentiation factor. Curr. Opin. Cell Biol. 3: 939-946.
25. low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor. Blood 109: 1460-1471.
26. NOCKA, K., J.C. TAN, E. CHIU, et al. 1990. Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. Embo. J. 9: 1805-1813.
27. KIMURA, Y., N. JONES, M. KLUPPEL, et al. 2004. Targeted mutations of the juxtamembrane tyrosines in the Kit receptor tyrosine kinase selectively affect multiple cell lineages. Proc. Natl. Acad. Sci. USA 101: 6015-6020.
28. FUKAO, T., T. YAMADA, M. TANABE, et al. 2002. Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice. Nat. Immunol. 3: 295-304.
29. VOSSELLER, K., G. STELLA, N.S. YEE & P. BESMER. 1997. c-kit receptor signaling through its phosphatidylinositide-3′-kinase-binding site and protein kinase C: role in mast cell enhancement of degranulation, adhesion, and membrane ruffling. Mol. Biol. Cell 8: 909-922.
30. BERROZPE G., I. TIMOKHINA, S. YUKL, et al. 1999. The Wsh, W57, and Ph Kit expression mutations define tissue-specific control elements located between 23 and 154 kb upstream of kit. Blood 94: 2658-2666.
31. LANTZ, C.S., J. BOESIGER, C.H. SONG, et al. 1998. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 392: 90-93.
32. KOHNO, M., S. YAMASAKI, V.L. TYBULEWICZ & T. SAITO. 2005. Rapid and large amount of autocrine IL-3 production is responsible for mast cell survival by IgE in the absence of antigen. Blood 105: 2059-2065.
33. KITAURA, J., J. SONG, M. TSAI, et al. 2003. Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI. Proc. Natl. Acad. Sci. USA 100: 12911-12916.
34. LORENTZ, A., D. SCHUPPAN, A. GEBER, et al. 2002. Regulatory effects of stem cell factor and interleukin-4 on adhesion of human mast cells to extracellular matrix proteins. Blood 99: 966-972.
35. TOWNSEND, J.M., G.P. FALLON, J.D. MATTHEWS, et al. 2000. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 13: 573-583.
36. FINOTTO, S., Y.A. MEKORI & D.D. METCALFE. 1997. Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems. J. Clin. Invest. 99: 1721-1728.
37. YAMAGUCHI, M., K. HIRAI, A. KOMIYA, et al. 2001. Regulation of mouse mast cell surface Fc epsilon RI expression by dexamethasone. Int. Immunol. 13: 843-851.
38. MORII, E., T. JIPPO, T. TSUJIMURA, et al. 1997. Abnormal expression of mouse mast cell protease 5 gene in cultured mast cells derived from mutant mi/mi mice. Blood 90: 3057-3066.
39. HODGKINSON, C.A., K.J. MOORE, A. NAKAYAMA, et al. 1993. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 74: 395-404.
40. TSAI, F.Y. & S.H. ORKIN. 1997. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 89: 3636-3643.
41. HARIGAE, H., S. TAKAHASHI, N. SUWABE, et al. 1998. Differential roles of GATA-1 and GATA-2 in growth and differentiation of mast cells. Genes Cells 3: 39-50.
42. MARTIN, D.I., L.I. ZON, G. MUTTER & S.H. ORKIN. 1990. Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages. Nature 344: 444-447.
43. MIGLIACCIO, A.R., R.A. RANA, M. SANCHEZ, et al. 2003. GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant. J. Exp. Med. 197: 281-296.
44. TSUJIMURA, T., E. MORII, M. NOZAKI, et al. 1996. Involvement of transcription factor encoded by the mi locus in the expression of c-kit receptor tyrosine kinase in cultured mast cells of mice. Blood 88: 1225-1233.
45. MORII, E., T. TSUJIMURA, T. K. JIPPO, et al. 1996. Regulation of mouse mast cell protease 6 gene expression by transcription factor encoded by the mi locus. Blood 88: 2488-2494.
46. OGIHARA, H., E. MORII, D.K. KIM, et al. 2001. Inhibitory effect of the transcription factor encoded by the mutant mi microphthalmia allele on transactivation of mouse mast cell protease 7 gene. Blood 97: 645-651.
47. WEISS, M.J. & S.H. ORKIN. 1995. GATA transcription factors: key regulators of hematopoiesis. Exp. Hematol. 23: 99-107.
48. JIPPO, T., H. MIZUNO, Z. XU, et al. 1996. Abundant expression of transcription factor GATA-2 in proliferating but not in differentiated mast cells in tissues of mice: demonstration by in situ hybridization. Blood 87: 993-998.
49. ZON, L.I., M.F. GURISH, R.L. STEVENS, et al. 1991. GATA-binding transcription factors in mast cells regulate the promoter of the mast cell carboxypeptidase A gene. J. Biol. Chem. 266: 22948-22953.
50. NISHIYAMA, C., T. YOKOTA, K. OKUMURA & C. RA. 1999. The transcription factors Elf-1 and GATA-1 bind to cell-specific enhancer elements of human high-affinity IgE receptor alpha-chain gene. J. Immunol. 163: 623-630.
51. MAEDA, K., C. NISHIYAMA, T. TOKURA, et al. 2003. Regulation of cell type-specific mouse Fc epsilon RI beta-chain gene expression by GATA-1 via four GATA motifs in the promoter. J. Immunol. 170: 334-340.
52. NISHIYAMA, C., T. ITO, M. NISHIYAMA, et al. 2005. GATA-1 is required for expression of Fc{varepsilon}RI on mast cells: analysis of mast cells derived from GATA-1 knockdown mouse bone marrow. Int. Immunol. 17: 847-856.
53. KAUSHANSKY, K. & J.G. DRACHMAN. 2002. The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production. Oncogene 21: 3359-3367.
54. SHIVDASANI, R.A., Y. FUJIWARA, M.A. MCDEVITT & S.H. ORKIN. 1997. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. Embo. J. 16: 3965-3973.
55. VYAS, P., K.AULT, C.W. JACKSON, et al. 1999. Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood 93: 2867-2875.
56. CENTURIONE, L., A. DI BALDASSARRE, M. ZINGARIELLO, et al. 2004. Increased and pathologic emperipolesis of neutrophils within megakaryocytes associated with marrow fibrosis in GATA-1(low) mice. Blood 104: 3573-3580.
57. VANNUCCHI, A.M., L. BIANCHI, C. CELLAI, et al. 2001. Accentuated response to phenylhydrazine and erythropoietin in mice genetically impaired for their Gata-1 expression (GATA-1low mice). Blood 97: 3040-3050.
58. VANNUCCHI, A.M., L. BIANCHI, C. CELLAI, et al. 2002. Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1low mice). Blood 100: 1123-1132.
59. ZHOU, W, C.F. TOOMBS, T. ZOU, et al. 1997. Transgenic mice overexpressing human cmpl ligand exhibit chronic thrombocytosis and display enhanced recovery from 5fluorouracil or antiplatelet serum treatment. Blood 89: 1551-1559.
60. YAN, X.Q., D. LACEY, C. FLETCHER, et al. 1995. Chronic exposure to retroviral vector encoded MGDF (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood 86: 4025-4033.
61. YAN, X.Q., D. LACEY, D. HILL, et al. 1996. A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation. Blood 88: 402-409.
62. VANNUCCHI, A.M., L. BIANCHI, F. PAOLETTI, et al. 2005. A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-beta1 in the development of myelofibrosis. Blood 105: 3493-3501.
63. YANAGIDA, M., Y. IDE, A. IMAI, et al. 1997. The role of transforming growth factor-beta in PEG-rHuMGDF-induced reversible myelofibrosis in rats. Br. J. Haematol. 99: 739-745.
64. SCHMITT, A., H. JOUAULT, J. GUICHARD, et al. 2000. Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis. Blood 96: 1342-1347.
65. KAUSHANSKY, K. 2003. Etiology of the myeloproliferative disorders: the role of thrombopoietin. Semin. Hematol. 40: 6-9.
66. MIGLIACCIO, A.R., A.M. VANNUCCHI, G. MIGLIACCIO & R. HOFFMAN. 2006. Molecular advances toward the understanding of the patho-biology of idiopathic myelofibrosis. Curr. Imm. Rev. 2: 169-186.
67. KAUSHANSKY, K. 2006. Lineage-specific hematopoietic growth factors. N. Engl. J. Med. 354: 2034-2045.
68. ALEXANDER, W.S., A.W. ROBERTS, N.A. NICOLA, et al. 1996. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. Blood 87: 2162-2170.
69. FOX, N., G. PRIESTLEY, T. PAPAYANNOPOULOU & K. KAUSHANSKY. 2002. Thrombopoietin expands hematopoietic stem cells after transplantation. J. Clin. Invest. 110: 389-394.
70. SUDA, T. 2006. Quiescent stem cells in the niche. 4th ISSCR Annual Meeting. Toronto.
71. SCADDEN, D.T. 2006. The stem-cell niche as an entity of action. Nature 441: 1075-1079.
72. SAWAI, N., K. KOIKE, H.H. MWAMTEMI, et al. 1999. Thrombopoietin augments stem cell factor-dependent growth of human mast cells from bone marrow multipotential hematopoietic progenitors. Blood 93: 3703-3712.
73. KIRSHENBAUM, A.S., C. AKIN, J.P. GOFF & D.D. METCALFE. 2005. Thrombopoietin alone or in the presence of stem cell factor supports the growth of KIT(CD117)low/ MPL(CD110) +human mast cells from hematopoietic progenitor cells. Exp. Hematol. 33: 413-421.